Back to Search
Start Over
DOSE-DENSE THERAPY (R-CHOP14) SEEMS TO OVERCOME THE NEGATIVE PROGNOSTIC SIGNIFICANCE OF B CELL ORIGIN IN DLBCL LYMPHOMA PATIENTS
- Authors :
- Rigacci, L.
Martelli, Maurizio
Puccini, B.
Di Lollo, S.
Finolezzi, E.
Nassi, L.
Doria, M.
Alterini, R.
Carrai, V.
Bosi, A.
- Publication Year :
- 2008
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.od......3686..d87c80996b3b8ee476570719bfe9b3af